Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016586404> ?p ?o ?g. }
- W2016586404 endingPage "2380" @default.
- W2016586404 startingPage "2378" @default.
- W2016586404 abstract "A high-affinity receptor for interleukin (IL)-13 (interleukin-13R alpha 2) is over-expressed in disease-related fibroblasts and neoplastic cells and is involved in cancer, allergic, and inflammatory diseases. The extracellular domain of IL-13R alpha2 (ECD alpha2) could be cleaved, which serves as a decoy receptor. We have expressed and purified ECD alpha2 in both Escherichia coli (E. coli) and mammalian systems as a soluble fragment and studied its biological activities. Although both products of ECD alpha2 showed IL-13 inhibitory activities, mammalian cell-derived ECD alpha2 appeared to be superior compared with purified protein from E. coli. When expressed in E. coli, ECD alpha2 appeared to be a monomer of 42 but a 60 kDa protein when purified from mammalian cells due to heavy glycosylation. The purified glycosylated ECD alpha2 efficiently inhibited IL-13-induced STAT6 phosphorylation in immune and Hodgkin's lymphoma cell lines, IL-13 binding, and cytotoxicity of IL-13 cytotoxin in various cancer cell lines. The improved potency of mammalian cell-derived ECD alpha2 was shown over ECD alpha2/Fc fusion protein. The N-linked glycosylation of ECD alpha2 was found to be essential for optimal IL-13 inhibitory activity as deglycosylation by PNGase F showed lower activity. ECD alpha2 did not inhibit IL-4-induced STAT6 phosphorylation, indicating that inhibitory effects of ECD alpha2 are receptor specific. These results indicate that glycosylated ECD alpha2 can serve as a potent inhibitor of IL-13 in a variety of conditions in which IL-13 is a key mediator, e.g., pulmonary, allergic, fibrotic, and neoplastic diseases." @default.
- W2016586404 created "2016-06-24" @default.
- W2016586404 creator A5004784274 @default.
- W2016586404 creator A5061122690 @default.
- W2016586404 creator A5067972591 @default.
- W2016586404 date "2006-10-03" @default.
- W2016586404 modified "2023-10-16" @default.
- W2016586404 title "N‐linked glycosylation of IL‐13R0'2 is essential for optimal IL‐13 inhibitory activity" @default.
- W2016586404 cites W1544553619 @default.
- W2016586404 cites W1561114331 @default.
- W2016586404 cites W1563053828 @default.
- W2016586404 cites W1965851103 @default.
- W2016586404 cites W1972497890 @default.
- W2016586404 cites W1982222256 @default.
- W2016586404 cites W1999822220 @default.
- W2016586404 cites W2012738581 @default.
- W2016586404 cites W2014707230 @default.
- W2016586404 cites W2023668782 @default.
- W2016586404 cites W2026179616 @default.
- W2016586404 cites W2029428013 @default.
- W2016586404 cites W2032546263 @default.
- W2016586404 cites W2042709868 @default.
- W2016586404 cites W2044673785 @default.
- W2016586404 cites W2045575773 @default.
- W2016586404 cites W2060763719 @default.
- W2016586404 cites W2066475464 @default.
- W2016586404 cites W2088415661 @default.
- W2016586404 cites W2089301184 @default.
- W2016586404 cites W2092080151 @default.
- W2016586404 cites W2104684508 @default.
- W2016586404 cites W2118202157 @default.
- W2016586404 cites W2124566107 @default.
- W2016586404 cites W2125805192 @default.
- W2016586404 cites W2132403618 @default.
- W2016586404 cites W2137146859 @default.
- W2016586404 cites W2138600707 @default.
- W2016586404 cites W2149093370 @default.
- W2016586404 cites W2152609353 @default.
- W2016586404 cites W2164262821 @default.
- W2016586404 cites W2168938667 @default.
- W2016586404 cites W2230578331 @default.
- W2016586404 cites W4249989212 @default.
- W2016586404 cites W4313333805 @default.
- W2016586404 doi "https://doi.org/10.1096/fj.06-5995fje" @default.
- W2016586404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17023392" @default.
- W2016586404 hasPublicationYear "2006" @default.
- W2016586404 type Work @default.
- W2016586404 sameAs 2016586404 @default.
- W2016586404 citedByCount "28" @default.
- W2016586404 countsByYear W20165864042012 @default.
- W2016586404 countsByYear W20165864042013 @default.
- W2016586404 countsByYear W20165864042017 @default.
- W2016586404 countsByYear W20165864042018 @default.
- W2016586404 countsByYear W20165864042019 @default.
- W2016586404 countsByYear W20165864042020 @default.
- W2016586404 countsByYear W20165864042022 @default.
- W2016586404 crossrefType "journal-article" @default.
- W2016586404 hasAuthorship W2016586404A5004784274 @default.
- W2016586404 hasAuthorship W2016586404A5061122690 @default.
- W2016586404 hasAuthorship W2016586404A5067972591 @default.
- W2016586404 hasConcept C116073593 @default.
- W2016586404 hasConcept C153911025 @default.
- W2016586404 hasConcept C170493617 @default.
- W2016586404 hasConcept C185592680 @default.
- W2016586404 hasConcept C202751555 @default.
- W2016586404 hasConcept C2777313579 @default.
- W2016586404 hasConcept C54355233 @default.
- W2016586404 hasConcept C55493867 @default.
- W2016586404 hasConcept C81885089 @default.
- W2016586404 hasConcept C86803240 @default.
- W2016586404 hasConceptScore W2016586404C116073593 @default.
- W2016586404 hasConceptScore W2016586404C153911025 @default.
- W2016586404 hasConceptScore W2016586404C170493617 @default.
- W2016586404 hasConceptScore W2016586404C185592680 @default.
- W2016586404 hasConceptScore W2016586404C202751555 @default.
- W2016586404 hasConceptScore W2016586404C2777313579 @default.
- W2016586404 hasConceptScore W2016586404C54355233 @default.
- W2016586404 hasConceptScore W2016586404C55493867 @default.
- W2016586404 hasConceptScore W2016586404C81885089 @default.
- W2016586404 hasConceptScore W2016586404C86803240 @default.
- W2016586404 hasIssue "13" @default.
- W2016586404 hasLocation W20165864041 @default.
- W2016586404 hasLocation W20165864042 @default.
- W2016586404 hasOpenAccess W2016586404 @default.
- W2016586404 hasPrimaryLocation W20165864041 @default.
- W2016586404 hasRelatedWork W1984939224 @default.
- W2016586404 hasRelatedWork W2034034393 @default.
- W2016586404 hasRelatedWork W2047284239 @default.
- W2016586404 hasRelatedWork W2321586048 @default.
- W2016586404 hasRelatedWork W2950294885 @default.
- W2016586404 hasRelatedWork W2950946645 @default.
- W2016586404 hasRelatedWork W2951143506 @default.
- W2016586404 hasRelatedWork W2952106524 @default.
- W2016586404 hasRelatedWork W2952783750 @default.
- W2016586404 hasRelatedWork W2092574026 @default.
- W2016586404 hasVolume "20" @default.
- W2016586404 isParatext "false" @default.
- W2016586404 isRetracted "false" @default.